日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

CXCL2 affects macrophage antitumor function and immunotherapy efficacy in esophageal squamous cell carcinoma through calcium signaling

CXCL2通过钙信号传导影响巨噬细胞的抗肿瘤功能和食管鳞状细胞癌的免疫治疗效果

期刊:Frontiers in Immunology
影响因子:5.9
doi:10.3389/fimmu.2026.1695387
Gu, Meiying; Liu, Zhenkun; Zhao, Xinlei; He, Wei; Song, Ruifeng; Liu, Tao; Liu, Xiaofeng; Huo, Jia; Yang, Hongyi; Zhao, Peng; Weng, Jialei; Du, Yabing
信号转导
CXCL2
免疫/内分泌
细胞生物学
巨噬细胞
巨噬细胞
肿瘤
肿瘤免疫
发表日期：2026
文献求助 收藏

Single-cell insights into tumor microenvironment heterogeneity and plasticity: transforming precision therapy in gastrointestinal cancers

单细胞视角揭示肿瘤微环境异质性和可塑性：革新胃肠道癌症的精准治疗

期刊:Journal of Experimental & Clinical Cancer Research
影响因子:12.8
doi:10.1186/s13046-025-03567-5
Weng, Jialei; Ju, Feng; Lyu, Zicheng; Fan, Ningbo; Smit, Daniel J; Xu, Wenxin; Wu, Xiaolin; Becker, Philip; Xu, Yinan; Schweiger, Michal R; Hillmer, Axel M; Harwig, Ralf; Gul, Sheraz; Link, Alexander; Meder, Lydia; Fang, Nan; Dong, Qiongzhu; Bruns, Christiane J; Ren, Ning; Zhao, Yue
肿瘤
肿瘤免疫
细胞生物学
肿瘤微环境
单细胞
发表日期：2025
文献求助 收藏

FMO2(+) cancer-associated fibroblasts sensitize anti-PD-1 therapy in patients with hepatocellular carcinoma

FMO2(+)癌相关成纤维细胞可增强肝细胞癌患者对PD-1抑制剂的敏感性

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2025-011648
Xu, Wenxin; Weng, Jialei; Zhao, Yufei; Xie, Peiyi; Xu, Minghao; Liu, Shaoqing; Yu, Qiang; Yu, Mincheng; Liang, Bugang; Chen, Junbo; Sun, Hui-Chuan; Li, Hui; Ye, Qinghai; Shen, Yinghao
成纤维细胞
肿瘤
肿瘤免疫
细胞生物学
PD-1
发表日期：2025
文献求助 收藏

Erratum: HMOX1+ macrophages determine immunosuppressive microenvironment and immunotherapy efficacy in hepatocellular carcinoma

更正：HMOX1+巨噬细胞决定肝细胞癌的免疫抑制微环境和免疫治疗疗效

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000861
Du, Yabing; Xu, Wenxin; Liu, Zhenkun; Wen, Peihao; Song, Ruifeng; Hao, Weiwei; Liu, Yating; Zhao, Xinlei; Gu, Meiying; Weng, Jialei; He, Wei
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

HMOX1+ macrophages determine immunosuppressive microenvironment and immunotherapy efficacy in hepatocellular carcinoma.

HMOX1+巨噬细胞决定肝细胞癌的免疫抑制微环境和免疫疗法疗效。

期刊:Hepatology Communications
影响因子:4.6
doi:10.1097/HC9.0000000000000815
Du Yabing, Xu Wenxin, Liu Zhenkun, Wen Peihao, Song Ruifeng, Hao Weiwei, Liu Yating, Zhao Xinlei, Gu Meiying, Weng Jialei, He Wei
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
细胞生物学
免疫/内分泌
发表日期：2025
文献求助 收藏

WWOX tuning of oleic acid signaling orchestrates immunosuppressive macrophage polarization and sensitizes hepatocellular carcinoma to immunotherapy

WWOX 调控油酸信号传导，进而调控免疫抑制性巨噬细胞极化，并使肝细胞癌对免疫疗法更加敏感。

期刊:Journal for ImmunoTherapy of Cancer
影响因子:10.6
doi:10.1136/jitc-2024-010422
Liu, Shaoqing; Yang, Shiguang; Xu, Min; Zhou, Qiang; Weng, Jialei; Hu, Zhiqiu; Xu, Minghao; Xu, Wenxin; Yi, Yong; Shi, Yi; Dong, Qiongzhu; Hung, Mien-Chie; Ren, Ning; Zhou, Chenhao
巨噬细胞
肿瘤
肿瘤免疫
巨噬细胞
信号转导
WWOX
细胞生物学
免疫/内分泌
发表日期：2024
文献求助 收藏

FGFR2 fusion/rearrangement is associated with favorable prognosis and immunoactivation in patients with intrahepatic cholangiocarcinoma

FGFR2融合/重排与肝内胆管癌患者的良好预后和免疫激活相关

期刊:Oncologist
影响因子:4.2
doi:10.1093/oncolo/oyae170
Liu, Shaoqing; Weng, Jialei; Cao, Manqing; Zhou, Qiang; Xu, Min; Xu, Wenxin; Hu, Zhiqiu; Xu, Minghao; Dong, Qiongzhu; Sheng, Xia; Zhou, Chenhao; Ren, Ning
肿瘤
肿瘤免疫
FGFR2
胆管癌
免疫/内分泌
发表日期：2024
文献求助 收藏

GTPBP4 promotes hepatocellular carcinoma progression and metastasis via the PKM2 dependent glucose metabolism

GTPBP4通过PKM2依赖的葡萄糖代谢促进肝细胞癌的进展和转移。

期刊:Redox Biology
影响因子:11.9
doi:10.1016/j.redox.2022.102458
Zhou, Qiang; Yin, Yirui; Yu, Mincheng; Gao, Dongmei; Sun, Jialei; Yang, Zhangfu; Weng, Jialei; Chen, Wanyong; Atyah, Manar; Shen, Yinghao; Ye, Qinghai; Li, Chia-Wei; Hung, Mien-Chie; Dong, Qiongzhu; Zhou, Chenhao; Ren, Ning
细胞生物学
肿瘤
肿瘤免疫
代谢
发表日期：2022
文献求助 收藏

The Age-Specific Features and Clinical Significance of NRF2 and MAPK10 Expression in HCC Patients

NRF2和MAPK10表达在肝细胞癌患者中的年龄特异性特征及其临床意义

期刊:International Journal of General Medicine
影响因子:2
doi:10.2147/IJGM.S351263
Atyah, Manar; Zhou, Chenhao; Zhou, Qiang; Chen, Wanyong; Weng, Jialei; Wang, Pengcheng; Shi, Yi; Dong, Qiongzhu; Ren, Ning
肿瘤
肿瘤免疫
NRF2
MAPK/ERK
细胞生物学
发表日期：2022
文献求助 收藏

Development and Validation of a Metabolic Gene-Based Prognostic Signature for Hepatocellular Carcinoma

肝细胞癌代谢基因预后特征的开发与验证

期刊:Journal of Hepatocellular Carcinoma
影响因子:3.4
doi:10.2147/JHC.S300633
Weng, Jialei; Zhou, Chenhao; Zhou, Qiang; Chen, Wanyong; Yin, Yirui; Atyah, Manar; Dong, Qiongzhu; Shi, Yi; Ren, Ning
细胞生物学
肿瘤
肿瘤免疫
代谢
发表日期：2021
文献求助 收藏